- Home
- SCKT vs BDRX Comparison
SCKT vs BDRX Comparison
Compare SCKT & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCKT
- BDRX
- Stock Information
- Founded
- SCKT 1992
- BDRX 2000
- Country
- SCKT United States
- BDRX United Kingdom
- Employees
- SCKT N/A
- BDRX N/A
- Industry
- SCKT Computer Manufacturing
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SCKT Technology
- BDRX Health Care
- Exchange
- SCKT Nasdaq
- BDRX Nasdaq
- Market Cap
- SCKT 9.3M
- BDRX 5.8M
- IPO Year
- SCKT 1995
- BDRX N/A
- Fundamental
- Price
- SCKT $1.23
- BDRX $0.88
- Analyst Decision
- SCKT
- BDRX
- Analyst Count
- SCKT 0
- BDRX 0
- Target Price
- SCKT N/A
- BDRX N/A
- AVG Volume (30 Days)
- SCKT 15.7K
- BDRX 3.1M
- Earning Date
- SCKT 07-30-2025
- BDRX 04-11-2025
- Dividend Yield
- SCKT N/A
- BDRX N/A
- EPS Growth
- SCKT N/A
- BDRX N/A
- EPS
- SCKT N/A
- BDRX N/A
- Revenue
- SCKT $17,750,643.00
- BDRX N/A
- Revenue This Year
- SCKT $8.62
- BDRX N/A
- Revenue Next Year
- SCKT N/A
- BDRX N/A
- P/E Ratio
- SCKT N/A
- BDRX N/A
- Revenue Growth
- SCKT 0.29
- BDRX N/A
- 52 Week Low
- SCKT $0.91
- BDRX $0.78
- 52 Week High
- SCKT $1.72
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- SCKT 64.88
- BDRX 38.47
- Support Level
- SCKT $1.13
- BDRX $0.82
- Resistance Level
- SCKT $1.25
- BDRX $0.90
- Average True Range (ATR)
- SCKT 0.05
- BDRX 0.08
- MACD
- SCKT 0.01
- BDRX 0.01
- Stochastic Oscillator
- SCKT 85.71
- BDRX 12.26
About SCKT Socket Mobile Inc.
Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.